78 related articles for article (PubMed ID: 7894336)
21. Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer.
Srkalovic G; Schally AV; Wittliff JL; Day TG; Jenison EL
Int J Oncol; 1998 Mar; 12(3):489-98. PubMed ID: 9472084
[TBL] [Abstract][Full Text] [Related]
22. Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
Krebs LJ; Wang X; Pudavar HE; Bergey EJ; Schally AV; Nagy A; Prasad PN; Liebow C
Cancer Res; 2000 Aug; 60(15):4194-9. PubMed ID: 10945629
[TBL] [Abstract][Full Text] [Related]
23. LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
Szepeshazi K; Schally AV; Halmos G
Int J Oncol; 2007 Jun; 30(6):1485-92. PubMed ID: 17487370
[TBL] [Abstract][Full Text] [Related]
24. Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer.
Fekete M; Wittliff JL; Schally AV
J Clin Lab Anal; 1989; 3(3):137-47. PubMed ID: 2569034
[TBL] [Abstract][Full Text] [Related]
25. Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement.
Zalatnai A; Schally AV
Int J Pancreatol; 1989 Mar; 4(2):149-60. PubMed ID: 2566638
[TBL] [Abstract][Full Text] [Related]
26. Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
Takeuchi Y; Takahashi M; Sakano K; Mutoh M; Niho N; Yamamoto M; Sato H; Sugimura T; Wakabayashi K
Carcinogenesis; 2007 Aug; 28(8):1692-6. PubMed ID: 17449904
[TBL] [Abstract][Full Text] [Related]
27. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model.
Ouyang N; Williams JL; Tsioulias GJ; Gao J; Iatropoulos MJ; Kopelovich L; Kashfi K; Rigas B
Cancer Res; 2006 Apr; 66(8):4503-11. PubMed ID: 16618778
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Kilian M; Gregor JI; Heukamp I; Hanel M; Ahlgrimm M; Schimke I; Kristiansen G; Ommer A; Walz MK; Jacobi CA; Wenger FA
Prostaglandins Leukot Essent Fatty Acids; 2006 Dec; 75(6):429-34. PubMed ID: 17034997
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor.
Takahashi M; Kitahashi T; Ishigamori R; Mutoh M; Komiya M; Sato H; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
Carcinogenesis; 2008 Aug; 29(8):1608-13. PubMed ID: 18567618
[TBL] [Abstract][Full Text] [Related]
31. Lack of involvement of metallothionein expression in pancreatic carcinogenesis by N-nitrosobis (2-oxopropyl) amine in Syrian hamsters.
Minami T; Sakita Y; Okazaki Y; Tsutsumi M; Konishi Y
Cell Mol Biol (Noisy-le-grand); 2000 Mar; 46(2):445-50. PubMed ID: 10774932
[TBL] [Abstract][Full Text] [Related]
32. Orotic acid enhancement of preneoplastic and neoplastic lesions induced in the pancreas and liver of hamsters by N-nitroso(2-hydroxypropyl) (2-oxopropyl)amine.
Kokkinakis DM; Albores-Saavedra J
Cancer Res; 1994 Oct; 54(20):5324-32. PubMed ID: 7923160
[TBL] [Abstract][Full Text] [Related]
33. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.
Halmos G; Arencibia JM; Schally AV; Davis R; Bostwick DG
J Urol; 2000 Feb; 163(2):623-9. PubMed ID: 10647698
[TBL] [Abstract][Full Text] [Related]
34. Bile-reflux into the pancreatic ducts is associated with the development of intraductal papillary carcinoma in hamsters.
Adachi T; Tajima Y; Kuroki T; Mishima T; Kitasato A; Fukuda K; Tsutsumi R; Kanematsu T
J Surg Res; 2006 Nov; 136(1):106-11. PubMed ID: 16863651
[TBL] [Abstract][Full Text] [Related]
35. Influence of antioxidative vitamins A, C and E on lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters.
Wenger FA; Kilian M; Ridders J; Stahlknecht P; Schimke I; Guski H; Jacobi CA; Müller JM
Prostaglandins Leukot Essent Fatty Acids; 2001 Sep; 65(3):165-71. PubMed ID: 11728167
[TBL] [Abstract][Full Text] [Related]
36. [Progress in the detection and changes in the treatment of prostatic cancer].
Mathé G
Sem Hop; 1982 Sep; 58(33):1863-6. PubMed ID: 6293061
[TBL] [Abstract][Full Text] [Related]
37. Glycan structure of blood group-A antigen in hamster normal tissues and pancreatic cancers.
Hirota M; Mogaki M; Pour PM; Chaney WG
Exp Mol Pathol; 1993 Jun; 58(3):169-78. PubMed ID: 8519344
[TBL] [Abstract][Full Text] [Related]
38. Electron microscopic autoradiography of the pancreas in the hamster treated with tritiated N-nitroso-2,6-dimethylmorpholine.
Reznik-Schüller HM; Lijinsky W; Hague BF
Cancer Res; 1980 Jul; 40(7):2245-51. PubMed ID: 6992982
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneously inoculated cells and implanted pancreatic cancer tissue show different patterns of metastases in Syrian golden hamsters.
Morioka CY; Saito S; Ohzawa K; Asano S; Hibino Y; Nakada Y; Kita KI; Watanabe A
JOP; 2000 Nov; 1(4):183-90. PubMed ID: 11856860
[TBL] [Abstract][Full Text] [Related]
40. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
